PTPN6 and prostate carcinoma: Additionally, SHP-1 deficiency in prostate cancer resulted in p27 accumulation, CDK6 reduction, retinoblastoma protein hypophosphorylation, cyclin E-CDK2 inhibition, and cycle arrest in phase G1 [86].